Joana Almaca, PhD

University of Miami

• Integrative Analysis of Multiomic Signatures and Cellular Function in Human Pancreas Across Developmental Timeline at Single-cell Spatial Resolution, Investigator

Paula Alonso-Guallart, DVM, PhD

New York Stem Cell Foundation

• Advanced Pancreatic-immune Organoid Models of Type 1 Diabetes Subtypes and Therapeutic Responses, Investigator

Mark S. Anderson, MD, PhD

University of California, San Francisco

• Role of Pancreatic Elastase in Beta Cell Health, Autoimmunity and Type 1 Diabetes, Investigator

Justin P. Annes, MD, PhD

University of California, San Francisco

• Developing a Platform Technology for β-Cell-Targeted Drug Delivery, Investigator

Amish Asthana, PhD

Wake Forest University Health Sciences

• A microwell perfusion plate for manufacturing and testing Islet-like clusters, Investigator

Mark Atkinson, PhD

University of Florida

• HPAP T1D: Human Pancreas Analysis Program for Type 1 Diabetes, Investigator
• HPAP T2D: Human Pancreas Analysis Program (Vanderbilt Univ.), Investigator

Dana Avrahami-Tzfati, PhD

Hadassah-Hebrew University

• The Role of Senescent Beta Cells in Type 1 Diabetes and Type 2 Diabetes, Investigator

Bradley Backes, PhD

• Driving Next Generation UPR Inhibitory Kinase Inhibitors for T1D, Investigator

Michael Betts, PhD

University of Pennsylvania

• HPAP T1D: Human Pancreas Analysis Program for Type 1 Diabetes, co-Investigator

Romina Bevacqua, PhD

Mount Sinai School of Medicine

• Identification of Novel Regulatory Mechanisms Driving Human Beta-Cell Maturation and Function, Investigator

Jason Bini, PhD

Yale School of Medicine

• Positron emission tomography to characterize beta cell mass in individuals from multiple stages in the progression of type 1 diabetes, Investigator

Rita Bottino, PhD

Allegheny Health Network

• HPAP T2D: Human Pancreas Analysis Program (Vanderbilt Univ.), Investigator

Michael Brehm, PhD

University of Massachusetts Medical School

• Models to Study the Synergy between Autoimmunity and Metabolism in T1D, Investigator

Marcela Brissova, PhD

Vanderbilt University

• Integrative Analysis of Multiomic Signatures and Cellular Function in Human Pancreas Across Developmental Timeline at Single-cell Spatial Resolution, Investigator
• HPAP T1D: Human Pancreas Analysis Program for Type 1 Diabetes, Co-Investigator
• HPAP T2D: Human Pancreas Analysis Program (Vanderbilt Univ.), Investigator
• PanKbase: A Community Hub for Integrated Pancreas Knowledge, Investigator

Noel Burtt

Broad Institute

• An Interactive Resource to Generate and Provide Integrated Knowledge of the Human Pancreas, Investigator

Alejandro Caicedo, PhD

University of Miami

• Integrative Analysis of Multiomic Signatures and Cellular Function in Human Pancreas Across Developmental Timeline at Single-cell Spatial Resolution, Investigator

Martha Campbell-Thompson, DVM PhD

University of Florida

• Survival and Potential of Insulin-deficient Beta Cells in Type 1 Diabetes, Investigator

Jean-Philippe Cartailler, PhD

Vanderbilt University

• PanKbase: A Community Hub for Integrated Pancreas Knowledge, Investigator

Shuibing Chen, PhD

Weill Cornell Medical College

• Decoding the Cell-specific Impact of Epigenomic and Alternative Splicing Regulation during T1D Progression, Investigator
• PanKbase: A Community Hub for Integrated Pancreas Knowledge, Investigator

Amit Choudhary, PhD

Broad Institute

• Development of platforms for beta cell-specific delivery and ligand discovery, Inveestigator

Paul Andrew Clemons, PhD

Broad Institute

• Development of platforms for beta cell-specific delivery and ligand discovery, Investigator

Aaron Cox, PhD

University of Texas Health Science Center at Houston

• GABP is a novel regulator of beta cell metabolism and proliferation, Investigator

Remi Creusot, PhD

Columbia University

• Understanding Thymic Epithelial and Hematopoietic Stem Cell-intrinsic Immune Abnormalities Driving T1D in Optimized HIS Mouse Models, Investigator

Chunhua Dai, MD

Vanderbilt University

• HPAP T2D: Human Pancreas Analysis Program (Vanderbilt Univ.), Co-Investigator

George Daley, MD, PhD

Harvard Medical School

• Models to Study the Synergy between Autoimmunity and Metabolism in T1D, Investigator

Saumya Das, MD, PhD

Massachusetts General Hospital

• Using ex vivo, in vivo Models and Patient Mutations to Interrogate Pancreatic Exocrine-Endocrine Cross Talk, Investigator

Thomas Delong, PhD

• The Role of Granular Acidification in the Pathogenesis of Type 1 Diabetes, Investigator

Nicolai Doliba, PhD

University of Pennsylvania

• HPAP T1D: Human Pancreas Analysis Program for Type 1 Diabetes, Research Staff
• HPAP T2D: Human Pancreas Analysis Program (Univ. Pennsylvania), Research Staff

Juan Dominguez-Bendala, PhD

University of Miami

• Using ex vivo, in vivo Models and Patient Mutations to Interrogate Pancreatic Exocrine-Endocrine Cross Talk, Investigator

Yuval Dor, PhD

Hebrew University of Jerusalem

• Beta Cell Death in early Type 1 Diabetes caused by Innate Immune Response to Inefficient RNA Editing, Consultant
• Survival and Potential of Insulin-deficient Beta Cells in Type 1 Diabetes, Investigator

Carmella Evans-Molina, MD, PhD

Indiana University

• Interferon Signaling in the T1D Islet Microenvironment, Investigator

Robert Babak Faryabi, PhD

University of Pennsylvania

• HPAP T1D: Human Pancreas Analysis Program for Type 1 Diabetes, Co-Investigator
• HPAP T2D: Human Pancreas Analysis Program (Univ. Pennsylvania), Co-Investigator

Michael Feldman, MD, PhD

University of Pennsylvania

• HPAP T1D: Human Pancreas Analysis Program for Type 1 Diabetes, co-Investigator
• HPAP T2D: Human Pancreas Analysis Program (Univ. Pennsylvania), Investigator

Jason Flannick, PhD

Broad Institute

• An Interactive Resource to Generate and Provide Integrated Knowledge of the Human Pancreas, Investigator

Accalia Fu, PhD

University of Massachusetts Medical School

• Models to Study the Synergy between Autoimmunity and Metabolism in T1D, Investigator

Kyle Gaulton, PhD

University of California, San Diego

• An Interactive Resource to Generate and Provide Integrated Knowledge of the Human Pancreas, Investigator

Benjamin Glaser, MD

Hadassah-Hebrew University

• The Role of Senescent Beta Cells in Type 1 Diabetes and Type 2 Diabetes, Investigator

Anna Gloyn, D Phil

Stanford University

• An Interactive Resource to Generate and Provide Integrated Knowledge of the Human Pancreas, Investigator
• HPAP T2D: Human Pancreas Analysis Program (Vanderbilt Univ.), Investigator

Peter Gottlieb, MD

University of Colorado at Denver

• The Role of Granular Acidification in the Pathogenesis of Type 1 Diabetes, Investigator

Manami Hara, PhD

University of Chicago

• Role of Pancreatic Elastase in Beta Cell Health, Autoimmunity and Type 1 Diabetes, Investigator

David Harlan, MD

University of Massachusetts Medical School

• Models to Study the Synergy between Autoimmunity and Metabolism in T1D, Investigator

Kevan Herold, MD

Yale University

• Advanced Pancreatic-immune Organoid Models of Type 1 Diabetes Subtypes and Therapeutic Responses, Investigator

Dirk Homann, MD

Mount Sinai Hospital

• HPAP T2D: Human Pancreas Analysis Program (Vanderbilt Univ.), Investigator

Chris Hughes, PhD

University of California at Irvine

• Studying the Mechanisms of Initiation and Progression of Beta Cell Death in T1D, Investigator

John Kaddis, PhD

City of Hope

• Human Islet Research Enhancement Center (HIREC), Principal Investigator

Klaus Kaestner, PhD

University of Pennsylvania

• HPAP T1D: Human Pancreas Analysis Program for Type 1 Diabetes, Investigator
• HPAP T2D: Human Pancreas Analysis Program (Univ. Pennsylvania), Investigator
• The Role of Senescent Beta Cells in Type 1 Diabetes and Type 2 Diabetes, Investigator
• Beta Cell Death in early Type 1 Diabetes caused by Innate Immune Response to Inefficient RNA Editing, Investigator

Richard Kibbey, MD, PhD

Yale University

• Advanced Pancreatic-immune Organoid Models of Type 1 Diabetes Subtypes and Therapeutic Responses, Investigator

Seung Kim, MD, PhD

Stanford University

• HPAP T2D: Human Pancreas Analysis Program (Vanderbilt Univ.), Investigator

Jacob Kitzman, PhD

University of Michigan

• Decoding the Cell-specific Impact of Epigenomic and Alternative Splicing Regulation during T1D Progression, Investigator

Tatsuyoshi Kono, PhD

• Interferon Signaling in the T1D Islet Microenvironment, Invetigator

Rohit Kulkarni, MD, PhD

Joslin Diabetes Center

• Development of platforms for beta cell-specific delivery and ligand discovery, Investigator
• Using ex vivo, in vivo Models and Patient Mutations to Interrogate Pancreatic Exocrine-Endocrine Cross Talk, Investigator
• Role of Pancreatic Elastase in Beta Cell Health, Autoimmunity and Type 1 Diabetes, Investigator

Irina Kusmartseva, PhD

University of Florida

• HPAP T1D: Human Pancreas Analysis Program for Type 1 Diabetes, Co-Investigator

Qin Li, PhD

• Beta Cell Death in early Type 1 Diabetes caused by Innate Immune Response to Inefficient RNA Editing, Investigator

Hening Lin, PhD

• Interferon Signaling in the T1D Islet Microenvironment, Investigator

Chengyang Liu, MD

University of Pennsylvania

• Decoding the Cell-specific Impact of Epigenomic and Alternative Splicing Regulation during T1D Progression, Investigator

Jing Liu, PhD

Indiana University-Purdue University

• Image based spatial transcriptomics to identify Beta Cell phenotypes in Type 1 Diabetes, Investigator
• PanKbase: A Community Hub for Integrated Pancreas Knowledge, Investigator

Jie Liu, PhD

University of Michigan

• Integrative Analysis of Multiomic Signatures and Cellular Function in Human Pancreas Across Developmental Timeline at Single-cell Spatial Resolution, Investigator

Kyle Loh, PhD

Stanford University

• Stem Cell-based Modeling of Type 1 Diabetes to Accelerate Translation of Therapies, Investigator

Patrick MacDonald, PhD

University of Alberta

• HPAP T2D: Human Pancreas Analysis Program (Vanderbilt Univ.), Investigator

Dustin Maly, PhD

University of Washington

• Driving Next Generation UPR Inhibitory Kinase Inhibitors for T1D, Invetigator

Mark Mamula, PhD

Yale University

• Advanced Pancreatic-immune Organoid Models of Type 1 Diabetes Subtypes and Therapeutic Responses, Investigator

Michael McManus, PhD

University of California, San Francisco

• iSTAR Tregs, Investigator

Jeffrey Millman, PhD

Washington University School of Medicine

• Studying the Mechanisms of Initiation and Progression of Beta Cell Death in T1D, Investigator

Raghavendra Mirmira, MD, PhD

University of Chicago

• Interferon Signaling in the T1D Islet Microenvironment, Investigator
• Role of Pancreatic Elastase in Beta Cell Health, Autoimmunity and Type 1 Diabetes, Investigator

Rick Monsma, PhD

New York Stem Cell Foundation

• Advanced Pancreatic-immune Organoid Models of Type 1 Diabetes Subtypes and Therapeutic Responses, Investigator

Jason Moore, PhD

University of Pennsylvania

• HPAP T1D: Human Pancreas Analysis Program for Type 1 Diabetes, co-Investigator
• HPAP T2D: Human Pancreas Analysis Program (Univ. Pennsylvania), Investigator

Ali Naji, MD, PhD

University of Pennsylvania

• HPAP T1D: Human Pancreas Analysis Program for Type 1 Diabetes, Investigator
• HPAP T2D: Human Pancreas Analysis Program (Univ. Pennsylvania), Investigator

Maki Nakayama, MD, PhD

University of Colorado at Denver

• The Role of Granular Acidification in the Pathogenesis of Type 1 Diabetes, Investigator

Ernesto Nakayasu, PhD

Pacific Northwest National Laboratory

• BioStructure & Function Team Leader, Investigator
• Interferon Signaling in the T1D Islet Microenvironment, Investigator

Joyce Niland, PhD

City of Hope

• Human Islet Research Enhancement Center (HIREC), Principal Investigator

Scott Oakes, MD

University of Chicago

• Interferon Signaling in the T1D Islet Microenvironment, Investigator
• Role of Pancreatic Elastase in Beta Cell Health, Autoimmunity and Type 1 Diabetes, Investigator

Peter Orchard, PhD

• Decoding the Cell-specific Impact of Epigenomic and Alternative Splicing Regulation during T1D Progression, Investigator

Feroz Papa, MD, PhD

University of California, San Francisco

• Driving Next Generation UPR Inhibitory Kinase Inhibitors for T1D, Investigator

Audrey Parent, PhD

University of California, San Francisco

• Stem Cell-based Modeling of Type 1 Diabetes to Accelerate Translation of Therapies, Investigator
• iSTAR Tregs, Investigator

Stephen Parker, PhD

University of Michigan

• Integrative Analysis of Multiomic Signatures and Cellular Function in Human Pancreas Across Developmental Timeline at Single-cell Spatial Resolution, Investigator
• Decoding the Cell-specific Impact of Epigenomic and Alternative Splicing Regulation during T1D Progression, Investigator
• PanKbase: A Community Hub for Integrated Pancreas Knowledge, Investigator

Al Powers, MD

Vanderbilt University

• Integrative Analysis of Multiomic Signatures and Cellular Function in Human Pancreas Across Developmental Timeline at Single-cell Spatial Resolution, Investigator
• HPAP T1D: Human Pancreas Analysis Program for Type 1 Diabetes, Investigator
• HPAP T2D: Human Pancreas Analysis Program (Vanderbilt Univ.), Investigator

Holger Russ, PhD

University of Florida

• Understanding Thymic Epithelial and Hematopoietic Stem Cell-intrinsic Immune Abnormalities Driving T1D in Optimized HIS Mouse Models, Investigator

Desmond Schatz, MD

University of Florida

• Survival and Potential of Insulin-deficient Beta Cells in Type 1 Diabetes, Investigator

Leonard Shultz, PhD

The Jackson Laboratory

• Models to Study the Synergy between Autoimmunity and Metabolism in T1D, Investigator

Emily Sims, MD

Indiana University School of Medicine

• Interferon Signaling in the T1D Islet Microenvironment, Investigator

Michael Stizel, PhD

Jackson Laboratory

• PanKbase: A Community Hub for Integrated Pancreas Knowledge, Investigator

Doris Stoffers, MD, PhD

University of Pennsylvania

• HPAP T1D: Human Pancreas Analysis Program for Type 1 Diabetes, co-Investigator
• HPAP T2D: Human Pancreas Analysis Program (Univ. Pennsylvania), Investigator

Megan Sykes, MD

Columbia University

• Understanding Thymic Epithelial and Hematopoietic Stem Cell-intrinsic Immune Abnormalities Driving T1D in Optimized HIS Mouse Models, Investigator

Qizhi Tang, PhD

University of California, San Francisco

• Tregs as Vehicles for Targeted Delivery of Therapeutic Payload to Human Islets, Investigator
• Stem Cell-based Modeling of Type 1 Diabetes to Accelerate Translation of Therapies, Investigator
• iSTAR Tregs, Investigator

Sarah Tersey, PhD

University of Chicago

• Interferon Signaling in the T1D Islet Microenvironment, Investigator

Luc Teyton, MD, PhD

• Studying the Mechanisms of Initiation and Progression of Beta Cell Death in T1D, Investigator

Golnaz Vahedi, PhD

University of Pennsylvania

• HPAP T1D: Human Pancreas Analysis Program for Type 1 Diabetes, Co-Investigator
• HPAP T2D: Human Pancreas Analysis Program (Univ. Pennsylvania), Co-Investigator
• Dissecting Transcriptomics and Epigenomic Signatures of Immune Cells in T1D, Investigator

Ben Voight, PhD

University of Pennsylvania

• An Interactive Resource to Generate and Provide Integrated Knowledge of the Human Pancreas, Investigator

Clive Wasserfall

University of Florida

• Survival and Potential of Insulin-deficient Beta Cells in Type 1 Diabetes, Investigator

Matthew Wortham, PhD

University of Colorado Anschutz Medical Campus

• Metabolic requirements of pancreatic beta cell proliferation, Investigator

Mingder Yang, PhD

University of Florida

• HPAP T1D: Human Pancreas Analysis Program for Type 1 Diabetes, Co-Investigator

Peng Yi, PhD

Joslin Diabetes Center

• Models to Study the Synergy between Autoimmunity and Metabolism in T1D, Investigator

David Zemmour, PhD

• Role of Pancreatic Elastase in Beta Cell Health, Autoimmunity and Type 1 Diabetes, Investigator

Han Zhu, PhD

University Colorado Anschutz Medical Campus

• Gene regulatory programs driving metabolic maturation of human pluripotent stem cell derived β-cells, Investigator